• LCI Is Sensitive Lung Function Parameter in Patients with Mild CF, Study Says
  • 1st Biosimilar of Dornase Alfa Inhalation Solution for CF Approved in Russia, Companies Announce
  • Progress for Cystic Fibrosis [INFOGRAPHIC]
  • Translate Bio Prioritizes Development of CF Therapy MRT5005, Other Lung Disease Candidates
  • Prenatal Testing for Cystic Fibrosis Influences Pregnancy Outcomes, Review Finds
  • Our Colons Need Your Help
  • Reflecting on the First Year of My Column, ‘Mutations & Conversations’
  • Armata Announces New Treatment Candidate for P. Aeruginosa Infections in CF Patients
  • New Agreement in Scotland Grants CF Patients Access to Orkambi and Symkevi
  • Safety, Early Effectiveness of POL6014 Confirmed in Phase 1 Trial
  • ICER Seeking Feedback on CF Treatments from Stakeholders
  • I Don’t Identify with the Word Disabled